| |
| Magyar Nephrologiai Társaság |
|
| Nefropatológiai Esetmegbeszélések |
 Rendezvény kezdete: 2024.04.11. | Rendezvény vége: 2024.04.11. |
| Helyszín: Online, |
| A rendezvény Web oldala: https://semmelweis.zoom.us/j/92742653268 |
A Semmelweis Egyetem Nefropatológiai Munkacsoportja és a Gyermekgyógyászati Klinika nefrológusai örömmel hívják meg a nefrológiával foglalkozó orvosokat/kutatókat a Nefropatológiai Esetmegbeszélések soron következő előadására, melyet online szervezünk.
Előadók klinikai részről: dr. Mikes Bálint, dr. Horváth Orsolya, dr. Agócs Róbert.
Időpont: 2024. április 11. csütörtök, 15:30
Link: https://semmelweis.zoom.us/j/92742653268
Esetek:
17 éves lány. Nephrosis syndroma, glomerularis hematuria, fél éve kisízületi panaszok. Lupus szerológia pozitív.
18 éves lány. Ismert lupus nephritises beteg 6. biopszia fellángolás miatt (2 g-os proteinuria).
8 éves fiú. Pneumonia és akut veseelégtelenség.
Dr. Dobi Deján
egyetemi adjunktus
SE Nefropatológiai munkacsoport
Semmelweis Egyetem
Patológiai, Igazságügyi és Biztosítási Orvostani Intézet |
|
|
 |
| |
| Magyar Nephrologiai Társaság |
|
| Nefropatológiai Esetmegbeszélések |
| Rendezvény kezdete: 2024.04.11. | Rendezvény vége: 2024.04.11. |
| Helyszín: Online, |
| A rendezvény Web oldala: https://semmelweis.zoom.us/j/92742653268 |
A Semmelweis Egyetem Nefropatológiai Munkacsoportja és a Gyermekgyógyászati Klinika nefrológusai örömmel hívják meg a nefrológiával foglalkozó orvosokat/kutatókat a Nefropatológiai Esetmegbeszélések soron következő előadására, melyet online szervezünk.
Előadók klinikai részről: dr. Mikes Bálint, dr. Horváth Orsolya, dr. Agócs Róbert.
Időpont: 2024. április 11. csütörtök, 15:30
Link: https://semmelweis.zoom.us/j/92742653268
Esetek:
17 éves lány. Nephrosis syndroma, glomerularis hematuria, fél éve kisízületi panaszok. Lupus szerológia pozitív.
18 éves lány. Ismert lupus nephritises beteg 6. biopszia fellángolás miatt (2 g-os proteinuria).
8 éves fiú. Pneumonia és akut veseelégtelenség.
Dr. Dobi Deján
egyetemi adjunktus
SE Nefropatológiai munkacsoport
Semmelweis Egyetem
Patológiai, Igazságügyi és Biztosítási Orvostani Intézet |
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| DC2012 - 12th International Symposium on Dendritic Cells |
| Rendezvény kezdete: 2012.10.07. | Rendezvény vége: 2012.10.11. |
| Munkahely neve: DC 2012 Secretariat |
| Címe: 1F Haeoreum B/D 748-5 Yeoksam-dong
Gangnam-gu Seoul 135-925 Korea |
| Tel: +82-2-577-8422,8423 |
| Fax: +82-2-566-6087 |
| E-mail: dc@people-x.com |
| Helyszín: Korea, Daegu, EXCO Convention Center |
| A rendezvény Web oldala: http://www.dc2012.kr/ |
The 12th International Symposium on Dendritic Cells
The DC2012 is hosted by the Korean Association of Immunologists and organized by the
Organizing Committee of the DC 2012.
The DC 2012 is anticipating more than 1,600 participants and industry representatives from 40
different countries. I truly believe that DC2012 would be the milestone for all of us to understand the
cutting-edge of research trends, to share valuable information and to build a network between
specialists in the field of dendritic cells.
Deadline of Abstract Submission is extended to June 30, 2012
re-registration: Extended to Sep. 14th, 2012!
Clinical Trial Satellite Meeting(Sponsored by JW CreaGene, BD)
*Date & Time: October 8~9, 2012 / 12:20~13:20
*Venue: 4F Auditorium, EXCO
*Confirmed Speakers:
1)TriMix Dentritic cell therapy in Melanoma - the Brussels`s experience
-Prof. Thielemans Kris (Vrije Universiteit Brussel, Belgium)
2)Applying Lessons learned from Provenge to the development of new immunotherapies for cancer
-Dr. James B. Trager (Dendreon Corporation, USA)
-The lunch will be served during the Clinical Trial Satellite Meeting.
-Maximum 300 persons can attend the meeting on a first-come, first-served basis. |
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| DC2012 - 12th International Symposium on Dendritic Cells |
| Rendezvény kezdete: 2012.10.07. | Rendezvény vége: 2012.10.11. |
| Munkahely neve: DC 2012 Secretariat |
| Címe: 1F Haeoreum B/D 748-5 Yeoksam-dong
Gangnam-gu Seoul 135-925 Korea |
| Tel: +82-2-577-8422,8423 |
| Fax: +82-2-566-6087 |
| E-mail: dc@people-x.com |
| Helyszín: Korea, Daegu, EXCO Convention Center |
| A rendezvény Web oldala: http://www.dc2012.kr/ |
The 12th International Symposium on Dendritic Cells
The DC2012 is hosted by the Korean Association of Immunologists and organized by the
Organizing Committee of the DC 2012.
The DC 2012 is anticipating more than 1,600 participants and industry representatives from 40
different countries. I truly believe that DC2012 would be the milestone for all of us to understand the
cutting-edge of research trends, to share valuable information and to build a network between
specialists in the field of dendritic cells.
Deadline of Abstract Submission is extended to June 30, 2012
re-registration: Extended to Sep. 14th, 2012!
Clinical Trial Satellite Meeting(Sponsored by JW CreaGene, BD)
*Date & Time: October 8~9, 2012 / 12:20~13:20
*Venue: 4F Auditorium, EXCO
*Confirmed Speakers:
1)TriMix Dentritic cell therapy in Melanoma - the Brussels`s experience
-Prof. Thielemans Kris (Vrije Universiteit Brussel, Belgium)
2)Applying Lessons learned from Provenge to the development of new immunotherapies for cancer
-Dr. James B. Trager (Dendreon Corporation, USA)
-The lunch will be served during the Clinical Trial Satellite Meeting.
-Maximum 300 persons can attend the meeting on a first-come, first-served basis. |
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| DC2012 - 12th International Symposium on Dendritic Cells |
| Rendezvény kezdete: 2012.10.07. | Rendezvény vége: 2012.10.11. |
| Munkahely neve: DC 2012 Secretariat |
| Címe: 1F Haeoreum B/D 748-5 Yeoksam-dong
Gangnam-gu Seoul 135-925 Korea |
| Tel: +82-2-577-8422,8423 |
| Fax: +82-2-566-6087 |
| E-mail: dc@people-x.com |
| Helyszín: Korea, Daegu, EXCO Convention Center |
| A rendezvény Web oldala: http://www.dc2012.kr/ |
The 12th International Symposium on Dendritic Cells
The DC2012 is hosted by the Korean Association of Immunologists and organized by the
Organizing Committee of the DC 2012.
The DC 2012 is anticipating more than 1,600 participants and industry representatives from 40
different countries. I truly believe that DC2012 would be the milestone for all of us to understand the
cutting-edge of research trends, to share valuable information and to build a network between
specialists in the field of dendritic cells.
Deadline of Abstract Submission is extended to June 30, 2012
re-registration: Extended to Sep. 14th, 2012!
Clinical Trial Satellite Meeting(Sponsored by JW CreaGene, BD)
*Date & Time: October 8~9, 2012 / 12:20~13:20
*Venue: 4F Auditorium, EXCO
*Confirmed Speakers:
1)TriMix Dentritic cell therapy in Melanoma - the Brussels`s experience
-Prof. Thielemans Kris (Vrije Universiteit Brussel, Belgium)
2)Applying Lessons learned from Provenge to the development of new immunotherapies for cancer
-Dr. James B. Trager (Dendreon Corporation, USA)
-The lunch will be served during the Clinical Trial Satellite Meeting.
-Maximum 300 persons can attend the meeting on a first-come, first-served basis. |
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| DC2012 - 12th International Symposium on Dendritic Cells |
| Rendezvény kezdete: 2012.10.07. | Rendezvény vége: 2012.10.11. |
| Munkahely neve: DC 2012 Secretariat |
| Címe: 1F Haeoreum B/D 748-5 Yeoksam-dong
Gangnam-gu Seoul 135-925 Korea |
| Tel: +82-2-577-8422,8423 |
| Fax: +82-2-566-6087 |
| E-mail: dc@people-x.com |
| Helyszín: Korea, Daegu, EXCO Convention Center |
| A rendezvény Web oldala: http://www.dc2012.kr/ |
The 12th International Symposium on Dendritic Cells
The DC2012 is hosted by the Korean Association of Immunologists and organized by the
Organizing Committee of the DC 2012.
The DC 2012 is anticipating more than 1,600 participants and industry representatives from 40
different countries. I truly believe that DC2012 would be the milestone for all of us to understand the
cutting-edge of research trends, to share valuable information and to build a network between
specialists in the field of dendritic cells.
Deadline of Abstract Submission is extended to June 30, 2012
re-registration: Extended to Sep. 14th, 2012!
Clinical Trial Satellite Meeting(Sponsored by JW CreaGene, BD)
*Date & Time: October 8~9, 2012 / 12:20~13:20
*Venue: 4F Auditorium, EXCO
*Confirmed Speakers:
1)TriMix Dentritic cell therapy in Melanoma - the Brussels`s experience
-Prof. Thielemans Kris (Vrije Universiteit Brussel, Belgium)
2)Applying Lessons learned from Provenge to the development of new immunotherapies for cancer
-Dr. James B. Trager (Dendreon Corporation, USA)
-The lunch will be served during the Clinical Trial Satellite Meeting.
-Maximum 300 persons can attend the meeting on a first-come, first-served basis. |
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| DC2012 - 12th International Symposium on Dendritic Cells |
| Rendezvény kezdete: 2012.10.07. | Rendezvény vége: 2012.10.11. |
| Munkahely neve: DC 2012 Secretariat |
| Címe: 1F Haeoreum B/D 748-5 Yeoksam-dong
Gangnam-gu Seoul 135-925 Korea |
| Tel: +82-2-577-8422,8423 |
| Fax: +82-2-566-6087 |
| E-mail: dc@people-x.com |
| Helyszín: Korea, Daegu, EXCO Convention Center |
| A rendezvény Web oldala: http://www.dc2012.kr/ |
The 12th International Symposium on Dendritic Cells
The DC2012 is hosted by the Korean Association of Immunologists and organized by the
Organizing Committee of the DC 2012.
The DC 2012 is anticipating more than 1,600 participants and industry representatives from 40
different countries. I truly believe that DC2012 would be the milestone for all of us to understand the
cutting-edge of research trends, to share valuable information and to build a network between
specialists in the field of dendritic cells.
Deadline of Abstract Submission is extended to June 30, 2012
re-registration: Extended to Sep. 14th, 2012!
Clinical Trial Satellite Meeting(Sponsored by JW CreaGene, BD)
*Date & Time: October 8~9, 2012 / 12:20~13:20
*Venue: 4F Auditorium, EXCO
*Confirmed Speakers:
1)TriMix Dentritic cell therapy in Melanoma - the Brussels`s experience
-Prof. Thielemans Kris (Vrije Universiteit Brussel, Belgium)
2)Applying Lessons learned from Provenge to the development of new immunotherapies for cancer
-Dr. James B. Trager (Dendreon Corporation, USA)
-The lunch will be served during the Clinical Trial Satellite Meeting.
-Maximum 300 persons can attend the meeting on a first-come, first-served basis. |
|
|
|
